Context Therapeutics settles governance lawsuit; annual director elections June 24, 2026

Context Therapeutics Inc.

Stipulated consent judgment filed Feb 24 invalidates three-year director terms and for-cause removal from charter.
Class action by Vladimir Gusinsky Revocable Trust will be dismissed with prejudice; charter corrected if court approves.
Annual meeting set for June 24, 2026; record date April 27, 2026; agenda includes election of directors to one-year terms.
Stockholder proposals and director nominations due by March 14, 2026; universal proxy notices due by April 13, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.